ELUTIA INC. (ELUT) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on September 7, 2023, covering events that occurred on September 6, 2023. The registrant, formerly known as Aziyo Biologics, Inc., is a Delaware corporation listed on the Nasdaq Capital Market. The filing documents a corporate name change and the associated update to its stock ticker symbol.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements or performance metrics.
Material Changes
- Corporate Name Change: On September 6, 2023, the Company changed its name from Aziyo Biologics, Inc. to Elutia Inc. via an amendment to its restated certificate of incorporation filed with the Delaware Secretary of State.
- Bylaws Amendment: The Company amended and restated its bylaws to reflect the new name.
- Stock Ticker Symbol: Class A common stock ceased trading under the symbol "AZYO" and began trading under the new symbol "ELUT" on the Nasdaq Capital Market prior to market open on September 7, 2023.
- Shareholder Rights: The name change did not require a stockholder vote and does not affect the rights of the Company's stockholders.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document focuses solely on the administrative execution of the name change.
Key Facts for Investor Verification
- Verify the new ticker symbol "ELUT" is active on the Nasdaq Capital Market.
- Confirm the legal name change to Elutia Inc. is reflected in subsequent filings and corporate records.
- Note that the former name, Aziyo Biologics, Inc., is no longer in use for the registrant.
- Review the attached press release (Exhibit 99.1) for any additional strategic context regarding the rebranding.